Agitation in Alzheimer Disease as a Qualifying Condition for Medical Marijuana in the United States

作者：Maust Donovan T^*; Bonar Erin E; Ilgen Mark A; Blow Frederic C; Kales Helen C

来源：American Journal of Geriatric Psychiatry, 2016, 24(11): 1000-1003.

DOI：10.1016/j.jagp.2016.03.006

• dementia
• neuropsychiatric symptoms
• agitation
• medical marijuana
• healthcare policy

Objective: To determine the extent to which states and localities include dementia as a qualifying condition for medical marijuana and how common this indication is. Methods: The authors reviewed authorizing legislation and medical marijuana program websites and annual reports for the states and localities where medical marijuana is legal. Results: Of the 24 states and localities where medical marijuana is legal, dementia is a qualifying condition in 10 (41.7%), primarily for agitation of Alzheimer disease. In the five states where information was available regarding qualifying conditions for certification, dementia was the indication for <0.5% of medical marijuana certifications. Conclusion: Dementia is somewhat commonly listed as a potential qualifying condition for medical marijuana. Currently, few applicants for medical marijuana list dementia as the reason for seeking certification. However, given increasingly open attitudes toward recreational and medical marijuana use, providers should be aware that dementia is a potential indication for licensing, despite lack of evidence for its efficacy.

• 出版日期2016-11